TY - JOUR
T1 - Expression and regulation of a low-density lipoprotein receptor exon 12 splice variant
AU - Ling, I. Fang
AU - Gopalra, Rangaraj K.
AU - Simpson, James F.
AU - Estus, Steven
PY - 2010/11
Y1 - 2010/11
N2 - As low-density lipoprotein receptor (LDLR) contributes to cholesterol and amyloid beta homeostasis, insights into LDLR regulation may facilitate our understanding of cardiovascular disease and Alzheimer's disease. Previously, we identified LDLR isoforms that lacked exon 12 or exons 11-12 and that are predicted to encode soluble, dominant negative, LDLR. Moreover, these isoforms were associated with rs688, an exon 12 polymorphism that was associated with LDL-cholesterol and Alzheimer's disease risk. In this study, we present evidence that although the truncated LDLR isoforms are translated in vitro, they represent < 0.1% of CSF proteins. As these LDLR isoforms likely represent a loss of mRNAencoding functional LDLR, we then focused upon identifying intron-exon boundary and exonic splicing enhancer elements critical to splicing. Exon 12 inclusion is enhanced by altering the 5' splice site in intron 12 towards a consensus splice donor sequence, consistent with its being a weak 5' splice site. Additionally, of the nine evolutionarily conserved putative splicing enhancer regions within exon 12, two regions that flank rs688 were critical to exon 12 inclusion. Overall, these results suggest that LDLR splice variants represent a loss of mRNA encoding functional LDLR and provide insights into the regulatory elements critical for LDLR exon 12 splicing.
AB - As low-density lipoprotein receptor (LDLR) contributes to cholesterol and amyloid beta homeostasis, insights into LDLR regulation may facilitate our understanding of cardiovascular disease and Alzheimer's disease. Previously, we identified LDLR isoforms that lacked exon 12 or exons 11-12 and that are predicted to encode soluble, dominant negative, LDLR. Moreover, these isoforms were associated with rs688, an exon 12 polymorphism that was associated with LDL-cholesterol and Alzheimer's disease risk. In this study, we present evidence that although the truncated LDLR isoforms are translated in vitro, they represent < 0.1% of CSF proteins. As these LDLR isoforms likely represent a loss of mRNAencoding functional LDLR, we then focused upon identifying intron-exon boundary and exonic splicing enhancer elements critical to splicing. Exon 12 inclusion is enhanced by altering the 5' splice site in intron 12 towards a consensus splice donor sequence, consistent with its being a weak 5' splice site. Additionally, of the nine evolutionarily conserved putative splicing enhancer regions within exon 12, two regions that flank rs688 were critical to exon 12 inclusion. Overall, these results suggest that LDLR splice variants represent a loss of mRNA encoding functional LDLR and provide insights into the regulatory elements critical for LDLR exon 12 splicing.
KW - Alzheimer's disease
KW - Cholesterol
KW - Low-density lipoprotein receptor
KW - RNA splicing
KW - Splicing regulatory element
UR - http://www.scopus.com/inward/record.url?scp=78651339208&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78651339208&partnerID=8YFLogxK
U2 - 10.1111/j.1471-4159.2010.06972.x
DO - 10.1111/j.1471-4159.2010.06972.x
M3 - Article
C2 - 20807319
AN - SCOPUS:78651339208
SN - 0022-3042
VL - 115
SP - 614
EP - 624
JO - Journal of Neurochemistry
JF - Journal of Neurochemistry
IS - 3
ER -